Cholesterol References
 

1. National Center for Health Statistics (NCHS), "Fast Stats: Cholesterol":

http://www.cdc.gov/nchs/fastats/cholest.htm

 

2. Kwiterovich PO Jr. The antiatherogenic role of high-density lipoprotein cholesterol.
Am J Cardiol, Nov. 1998, 82:9A, 13Q-21Q

 

3. Pizzorno JE and Murray MT, eds. Encyclopedia of Natural Medicine, revised 2nd edition, CA: Prima Publishing, 1998: 351-353.

 

4. Illingworth DR et al. Comparative effects of lovastatin and niacin in primary hypercholesterolemia. Arch Intern Med 1994 (154): 1586-95.

 

5. Vega GL et al. Lipoprotein responses to treatment with lovastatin, gemfibrozil, and nicotinic acid in normolipidemic patients with hypoalphalipopproteinemia. Arch Intern Med 1994 (154): 73-82.

 

6. Arsenio L et al. Effectiveness of long-term treatment with pantethine in patients with dyslipidemias. Clin Ther 1986 (8): 537-45.

 

7. Gaddi A et al. Controlled evaluation of pantethine, a natural hypolipidemic compound, in patients with diferent forms of hyperlipoproteinemia. Atheroscl 1984 (50): 73-83.

 

8. Bertolini S, et al. Lipoprotein changes induced by pantethine in hyperlipoproteinemic patients: adults and children. Int J Clin Pharmacol Ther Toxicol. 1986;24(11):630-7. 11.

 

9. Binaghi P, et al. Evaluation of the cholesterol-lowering effectiveness of pantethine in women in perimenopausal age. Minerva Med. Jun1990;81(6):475-479.
 

10. Simon JA. Vitamin C and cardiovascular disease: a review. J Am Coll Nutr 1992 (11): 107-25.

 

11. Howard PA et al. Effect of vitamin c on plasma lipids. Pharmacother 1995 (29): 1129-36.

 

12. Jacques PF et al. Ascorbic acid and plasma lipids.  Epidemiology 1994 (5): 19-26.

 

13. Hallfrisch J et al. High plasma vitamin C associated with high plasma HDL and HDL2 cholesterol. Am J Clin Nutr 1994 (60): 100-5.

 

14. Simon JA, et al. Relation of Serum Ascorbic Acid to Serum Lipids and Lipoproteins in US Adults. J Am Coll Nutr. 1998;17(3):250-5.
 

15.  Lynch SM, et al. Ascorbic acid and atherosclerotic cardiovascular disease. Subcell Biochem. 1996;25:331-67.
 

16. Chan AC. Vitamin E and atherosclerosis. J Nutr. 1998;128(10):1593-6.
 

17. Tsai PJ, Lu SC. Fish oil lowers plasma lipid concentrations and increases the susceptibility of low density lipoprotein to oxidative modification in healthy men. J Formos Med Assoc 1997 96(9): 718-26.

 

18. Morcos NC. Modulation of lipid profile by fish oil and garlic combination. J Natl Med Assoc 1997 89(10): 673078.

 

19. Kirk EA, Sutherland P, Wang SA, Chait A, LeBoeuf RC. Dietary isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor-deficient mice. J Nutr 1998 128(6): 954-59

 

20. Anderson JW, Cook-Newell ME, Johnstone BM. Meta-Analysis of the Effects of Soy Protein Intake on Serum Lipids. N Eng J Med. Aug1995;333:5.

 

21. Steiner M, et al. A Double-blind Crossover Study in Moderately Hypercholesterolemic Men that Compared the Effect of Aged Garlic Extract and Placebo Administration on Blood Lipids. Am J Clin Nutr. 1996;64(6):866-70.
 

22. Agarwal KC. Therapeutic Actions of Garlic Constituents. Med Res Rev. 1996;16(1):111-24.
 

23. Warshafsky S et al. Effect of garlic on total serum cholesterol. A meta-analysis.  Ann Intern Med 1993 (119): 599-605

 

24. Jain AK et al. Can Garlic reduce levels of serum lipids? A controlled clinical study. Am J Med 1993 (94): 632-5.

 

25. Canetti M, et al. A two-year study on the efficacy and tolerability of policosanol in patients with type II hyperlipoproteinaemia. Int J Clin Pharmacol Res. 1995;15(4):159-65.
 

26. Mas R, et al. Effects of policosanol in patients with type II hypercholesterolemia and additional coronary risk factors. Clin Pharmacol Ther. Apr1999;65(4):439-47.
 

27. Prat H, et al. Comparative effects of policosanol and two HMG-CoA reductase inhibitors on type II hypercholesterolemia. Rev Med Chil. Mar1999;127(3):286-94.
 

28. Nityanand S et al. Clinical trials with gugulipid, a new hypolipidaemic agent. J Assoc Physicians India 1989 (37): 321-8.
 

29. Haskell WL, et al. Role of water-soluble dietary fiber in the management of elevated plasma cholesterol in healthy subjects. Am J Cardiol. Feb1992;69(5):433-9.
 

30. Brown L, et al. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr. Jan1999;69(1):30-42.
 

31. Davidson MH, et al. Long-term effects of consuming foods containing psyllium seed husk on serum lipids in subjects with hypercholesterolemia. Am J Clin Nutr. Mar1998;67(3):367-76.
 

32. Anderson JW, et al. Long-term cholesterol-lowering effects of psyllium as an adjunct

to diet therapy in the treatment of hypercholesterolemia. Am J Clin Nutr. Jun2000;71(6):1433-1438.
 

33. Trautwein EA, et al. Psyllium, not pectin or guar gum, alters lipoprotein and biliary bile acid composition and fecal sterol excretion in the hamster. Lipids. Jun1998;33(6):573-82.
 

34.  Anderson JW, et al. Cholesterol-lowering effects of psyllium intake adjunctive to diet therapy in men and women with hypercholesterolemia: meta-analysis of 8 controlled trials. Am J Clin Nutr. Feb2000;71(2):472-9.
 

35. Life Extension eds., Disease Prevention and Treatment, 4th ed. Florida: Life Extension Media, 2003.

 

Return to Cholesterol Introduction